Melatonin influences the biological characteristics of keloid fibroblasts through the Erk and Smad signalling pathways. Issue 1 (1st March 2023)
- Record Type:
- Journal Article
- Title:
- Melatonin influences the biological characteristics of keloid fibroblasts through the Erk and Smad signalling pathways. Issue 1 (1st March 2023)
- Main Title:
- Melatonin influences the biological characteristics of keloid fibroblasts through the Erk and Smad signalling pathways
- Authors:
- Huang, Shaobin
Deng, Wuguo
Dong, Yunxian
Hu, Zhicheng
Zhang, Yi
Wang, Peng
Cao, Xiaoling
Chen, Miao
Cheng, Pu
Xu, Hailin
Zhu, Wenkai
Tang, Bing
Zhu, Jiayuan - Abstract:
- Abstract: Background: Keloids are abnormal fibrous hyperplasias that are difficult to treat. Melatonin can be used to inhibit the development of certain fibrotic diseases but has never been used to treat keloids. We aimed to discover the effects and mechanisms of melatonin in keloid fibroblasts (KFs). Methods: Flow cytometry, CCK-8 assays, western blotting, wound-healing assays, transwell assays, collagen gel contraction assays and immunofluorescence assays were applied to demonstrate the effects and mechanisms of melatonin in fibroblasts derived from normal skin, hypertrophic scars and keloids. The therapeutic potential of the combination of melatonin and 5-fluorouracil (5-FU) was investigated in KFs. Results: Melatonin significantly promoted cell apoptosis and inhibited cell proliferation, migration and invasion, contractile capability and collagen production in KFs. Further mechanistic studies demonstrated that melatonin could inhibit the cAMP/PKA/Erk and Smad pathways through the membrane receptor MT2 to alter the biological characteristics of KFs. Moreover, the combination of melatonin and 5-FU remarkably promoted cell apoptosis and inhibited cell migration and invasion, contractile capability and collagen production in KFs. Furthermore, 5-FU suppressed the phosphorylation of Akt, mTOR, Smad3 and Erk, and melatonin in combination with 5-FU markedly suppressed the activation of the Akt, Erk and Smad pathways. Conclusions: Collectively, melatonin may inhibit the Erk andAbstract: Background: Keloids are abnormal fibrous hyperplasias that are difficult to treat. Melatonin can be used to inhibit the development of certain fibrotic diseases but has never been used to treat keloids. We aimed to discover the effects and mechanisms of melatonin in keloid fibroblasts (KFs). Methods: Flow cytometry, CCK-8 assays, western blotting, wound-healing assays, transwell assays, collagen gel contraction assays and immunofluorescence assays were applied to demonstrate the effects and mechanisms of melatonin in fibroblasts derived from normal skin, hypertrophic scars and keloids. The therapeutic potential of the combination of melatonin and 5-fluorouracil (5-FU) was investigated in KFs. Results: Melatonin significantly promoted cell apoptosis and inhibited cell proliferation, migration and invasion, contractile capability and collagen production in KFs. Further mechanistic studies demonstrated that melatonin could inhibit the cAMP/PKA/Erk and Smad pathways through the membrane receptor MT2 to alter the biological characteristics of KFs. Moreover, the combination of melatonin and 5-FU remarkably promoted cell apoptosis and inhibited cell migration and invasion, contractile capability and collagen production in KFs. Furthermore, 5-FU suppressed the phosphorylation of Akt, mTOR, Smad3 and Erk, and melatonin in combination with 5-FU markedly suppressed the activation of the Akt, Erk and Smad pathways. Conclusions: Collectively, melatonin may inhibit the Erk and Smad pathways through the membrane receptor MT2 to alter the cell functions of KFs, while combination with 5-FU could exert even more inhibitory effects in KFs through simultaneous suppression of multiple signalling pathways. … (more)
- Is Part Of:
- Burns and trauma. Volume 11:Issue 1(2023)
- Journal:
- Burns and trauma
- Issue:
- Volume 11:Issue 1(2023)
- Issue Display:
- Volume 11, Issue 1 (2023)
- Year:
- 2023
- Volume:
- 11
- Issue:
- 1
- Issue Sort Value:
- 2023-0011-0001-0000
- Page Start:
- Page End:
- Publication Date:
- 2023-03-01
- Subjects:
- Keloid; Fibroblast -- Melatonin -- 5-fluorouracil -- Erk -- Smad -- Signalling pathways -- Hyperplasias -- Phosphorylation
Burns and scalds -- Periodicals
Wounds and injuries -- Periodicals
617.11 - Journal URLs:
- http://link.springer.com/ ↗
http://www.burnstrauma.com/ ↗
http://link.springer.com/journal/volumesAndIssues/41038 ↗
https://academic.oup.com/burnstrauma ↗ - DOI:
- 10.1093/burnst/tkad005 ↗
- Languages:
- English
- ISSNs:
- 2321-3876
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 26600.xml